Immunoglobulins, Intravenous

"Immunoglobulins, Intravenous" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Immunoglobulin preparations used in intravenous infusion, containing primarily IMMUNOGLOBULIN G. They are used to treat a variety of diseases associated with decreased or abnormal immunoglobulin levels including pediatric AIDS; primary HYPERGAMMAGLOBULINEMIA; SCID; CYTOMEGALOVIRUS infections in transplant recipients, LYMPHOCYTIC LEUKEMIA, CHRONIC; Kawasaki syndrome, infection in neonates, and IDIOPATHIC THROMBOCYTOPENIC PURPURA.

Descriptor ID	D016756
MeSH Number(s)	D12.776.124.486.485.114.619.393.536 D12.776.124.486.485.114.632 D12.776.124.790.651.114.632 D12.776.377.715.548.114.632
Concept/Terms	Immunoglobulins, Intravenous Immunoglobulins, Intravenous Intravenous IG Intravenous Antibodies IVIG Immune Globulin, Intravenous Intravenous Immune Globulin Antibodies, Intravenous Intravenous Immunoglobulins IV Immunoglobulins Immunoglobulins, IV Flebogamma DIF Flebogamma DIF Gamimune Gamimune Gamimmune Gamimune N Gamimune N Gamimmune N Gammagard Gammagard Iveegam Gammonativ Gammonativ Gamunex Gamunex Globulin-N Globulin-N Globulin N GlobulinN Intraglobin Intraglobin Intraglobin F Intraglobin F Intravenous Immunoglobulins, Human Intravenous Immunoglobulins, Human Human Intravenous Immunoglobulins Immunoglobulins, Human Intravenous Immune Globulin Intravenous (Human) Immunoglobulins, Intravenous, Human Modified Immune Globulin (Anti-Echovirus Antibody) Modified Immune Globulin (Anti-Echovirus Antibody) Privigen Privigen Venimmune Sandoglobulin Sandoglobulin Venoglobulin Venoglobulin Venoglobulin-I Venoglobulin-I Venoglobulin I VenoglobulinI Alphaglobin Alphaglobin Endobulin Endobulin

Below are MeSH descriptors whose meaning is more general than "Immunoglobulins, Intravenous".

Chemicals and Drugs [D]
Amino Acids, Peptides, and Proteins [D12]
Proteins [D12.776]
Blood Proteins [D12.776.124]
Immunoproteins [D12.776.124.486]
Immunoglobulins [D12.776.124.486.485]
Antibodies [D12.776.124.486.485.114]
Immunoglobulin Isotypes [D12.776.124.486.485.114.619]
Immunoglobulin G [D12.776.124.486.485.114.619.393]
Immunoglobulins, Intravenous [D12.776.124.486.485.114.619.393.536]
Immunoglobulins, Intravenous [D12.776.124.486.485.114.632]
Serum Globulins [D12.776.124.790]
Immunoglobulins [D12.776.124.790.651]
Antibodies [D12.776.124.790.651.114]
Immunoglobulins, Intravenous [D12.776.124.790.651.114.632]
Globulins [D12.776.377]
Serum Globulins [D12.776.377.715]
Immunoglobulins [D12.776.377.715.548]
Antibodies [D12.776.377.715.548.114]
Immunoglobulins, Intravenous [D12.776.377.715.548.114.632]

Below are MeSH descriptors whose meaning is related to "Immunoglobulins, Intravenous".

Below are MeSH descriptors whose meaning is more specific than "Immunoglobulins, Intravenous".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Immunoglobulins, Intravenous" by people in this website by year, and whether "Immunoglobulins, Intravenous" was a major or minor topic of these publications.

Bar chart showing 72 publications over 26 distinct years, with a maximum of 6 publications in 2010 and 2011

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1995	0	1	1
1997	1	1	2
2000	1	0	1
2001	0	1	1
2002	4	1	5
2003	2	2	4
2004	4	1	5
2005	5	0	5
2006	1	2	3
2007	4	1	5
2008	2	0	2
2009	1	1	2
2010	4	2	6
2011	4	2	6
2012	1	0	1
2013	0	1	1
2014	1	2	3
2015	0	2	2
2016	1	0	1
2017	0	1	1
2019	1	0	1
2020	1	3	4
2021	2	0	2
2022	2	2	4
2023	1	1	2
2024	0	2	2

Below are the most recent publications written about "Immunoglobulins, Intravenous" by people in Profiles.

Dalakas MC. Post-COVID Small Fiber Neuropathy, Implications of Innate Immunity, and Challenges on IVIG Therapy. Neurol Neuroimmunol Neuroinflamm. 2024 May; 11(3):e200248.

View in: PubMed
Kulkarni T, Criner GJ, Kass DJ, Rosas IO, Scholand MB, Dilling DF, Summer R, Duncan SR. Design of the STRIVE-IPF trial- study of therapeutic plasma exchange, rituximab, and intravenous immunoglobulin for acute exacerbations of idiopathic pulmonary fibrosis. BMC Pulm Med. 2024 Mar 20; 24(1):143.

View in: PubMed
Dalakas MC. Severe Stiff-Person Syndrome After COVID. Neurol Neuroimmunol Neuroinflamm. 2024 Mar; 11(2):e200192.

View in: PubMed
Dalakas MC, Latov N, Kuitwaard K. Intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): mechanisms of action and clinical and genetic considerations. Expert Rev Neurother. 2022 Nov-Dec; 22(11-12):953-962.

View in: PubMed
Oaklander AL, Dalakas MC. Reader Response: Intravenous Immunoglobulin Therapy in Patients With Painful Idiopathic Small-Fiber Neuropathy. Neurology. 2022 10 11; 99(15):675-676.

View in: PubMed
Liu E, Smyth RL, Li Q, Qaseem A, Florez ID, Mathew JL, Amer YS, Estill J, Lu Q, Fu Z, Lu X, Chan ES, Schwarze J, Wong GW, Fukuoka T, Ahn HS, Lee MS, Nurdiati D, Cao B, Tu W, Qian Y, Zhao S, Dong X, Luo X, Chen Z, Li G, Zhang X, Zhao X, Xu H, Xu F, Shi Y, Zhao R, Zhao Y, Lei J, Zheng X, Wang M, Yang S, Feng X, Wu L, He Z, Liu S, Wang Q, Song Y, Luo Z, Zhou Q, Guyatt G, Chen Y, Li Q. Guidelines for the prevention and management of children and adolescents with COVID-19. Eur J Pediatr. 2022 Dec; 181(12):4019-4037.

View in: PubMed
Yi J, Dalakas MC. Long-term Effectiveness of IVIg Maintenance Therapy in 36 Patients With GAD Antibody-Positive Stiff-Person Syndrome. Neurol Neuroimmunol Neuroinflamm. 2022 Sep; 9(5).

View in: PubMed
Dalakas MC, Meisel A. Immunomodulatory effects and clinical benefits of intravenous immunoglobulin in myasthenia gravis. Expert Rev Neurother. 2022 Apr; 22(4):313-318.

View in: PubMed
Dalakas MC. Update on Intravenous Immunoglobulin in Neurology: Modulating Neuro-autoimmunity, Evolving Factors on Efficacy and Dosing and Challenges on Stopping Chronic IVIg Therapy. Neurotherapeutics. 2021 10; 18(4):2397-2418.

View in: PubMed
Dalakas MC, Bitzogli K, Alexopoulos H. Anti-SARS-CoV-2 Antibodies Within IVIg Preparations: Cross-Reactivities With Seasonal Coronaviruses, Natural Autoimmunity, and Therapeutic Implications. Front Immunol. 2021; 12:627285.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement